David A Posner, MD
Family Practice · Fairfield
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: Sutter Medical Center, Sacramento · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Posner’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A126918 · Current
Licensed to practise in California · since 2013 · expires 2027-03-31 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$39,874
Medicare paid this office $39,874 for 316 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 210 | $19,459 | $89 |
| Long return visit (40+ min) | 74 | $9,397 | $124 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 24 | $3,355 | $140 |
| New patient visit (45+ min) | 32 | $3,202 | $100 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1,207 | $50 |
See all 12 services
| Return visit (30+ min) | 210 | $19,459 | $89 |
| Long return visit (40+ min) | 74 | $9,397 | $124 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 24 | $3,355 | $140 |
| New patient visit (45+ min) | 32 | $3,202 | $100 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 24 | $1,207 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $237 | $11 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $195 | $16 |
| Blood test, basic group of blood chemicals (calcium, ionized) | 14 | $188 | $13 |
| Injection of drug or substance under skin or into muscle | 14 | $159 | $11 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 14 | $137 | $8 |
| Insertion of needle into vein for collection of blood sample | 11 | $95 | $9 |
| Automated urinalysis test | 42 | $92 | $2 |
Who their Medicare patients are
316 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 21% · Women 61% · Also on Medicaid 21% · Health risk score 1.05. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 72% · Diabetes 32% · Chronic kidney disease 28% · Coronary heart disease 27% · Depression 23% · Atrial fibrillation 16% · Heart failure 15% · COPD 15% · Cancer 13% · Stroke 8% · Dementia 6%.
The office billed $155,913, Medicare allowed $57,899 and paid $39,874; for 644 services of 41 kinds; $510 of it was for drugs given in the office and $39,364 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 316 | 644 | 75 | 1.05 | $155,913 | $39,874 |
| 2023 | 300 | 567 | 76 | 1.08 | $128,983 | $37,015 |
| 2022 | 323 | 657 | 74 | 1.17 | $162,345 | $48,988 |
| 2021 | 341 | 790 | 72 | 1.10 | $197,804 | $63,416 |
| 2020 | 361 | 812 | 71 | 1.23 | $199,305 | $53,502 |
| 2019 | 402 | 923 | 72 | 1.22 | $206,081 | $53,465 |
| 2018 | 349 | 882 | 71 | 1.35 | $191,169 | $52,089 |
| 2017 | 363 | 861 | 71 | 1.26 | $173,816 | $50,551 |
| 2016 | 272 | 650 | 73 | 1.14 | $120,320 | $33,945 |
| 2015 | 84 | 168 | 74 | 1.16 | $33,341 | $10,585 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 222 | $21,765 | $95 |
| Long return visit (40+ min) | 45 | $6,221 | $138 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 18 | $2,516 | $140 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 34 | $1,710 | $50 |
| New patient visit (45+ min) | 12 | $1,560 | $130 |
| Short return visit (20+ min) | 13 | $619 | $48 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $299 | $11 |
| Detection test by immunoassay with direct visual observation for influenza virus | 17 | $276 | $16 |
| Injection of drug or substance under skin or into muscle | 20 | $238 | $12 |
| Detection test by immunoassay technique for streptococcus, group a (strep) | 11 | $181 | $16 |
| Automated urinalysis test | 31 | $70 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 15 | $14 | None |
2022: 9 services
| Return visit (30+ min) | 278 | $34,112 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,402 | $148 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 50 | $2,635 | $51 |
| Long return visit (40+ min) | 19 | $2,548 | $127 |
| Short return visit (20+ min) | 37 | $2,100 | $53 |
| Detection test by immunoassay with direct visual observation for influenza virus | 20 | $326 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 18 | $309 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $189 | $12 |
| Automated urinalysis test | 26 | $57 | $2 |
2021: 10 services
| Return visit (30+ min) | 295 | $43,415 | $99 |
| Long return visit (40+ min) | 30 | $4,973 | $155 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 31 | $4,642 | $150 |
| Short return visit (20+ min) | 38 | $2,542 | $62 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 35 | $1,796 | $51 |
| Influenza vaccine split virus, preservative free | 14 | $914 | $65 |
| Administration of influenza virus vaccine | 16 | $317 | $20 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 13 | $295 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $203 | $12 |
| Automated urinalysis test | 29 | $65 | $2 |
2020: 10 services
| Return visit (30+ min) | 297 | $36,030 | $81 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,747 | $134 |
| Short return visit (20+ min) | 54 | $3,039 | $53 |
| Long return visit (40+ min) | 22 | $2,740 | $105 |
| Influenza vaccine split virus, preservative free | 26 | $1,565 | $60 |
| Administration of influenza virus vaccine | 28 | $503 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | $424 | $14 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $263 | $16 |
| Detection test by immunoassay with direct visual observation for influenza virus | 16 | $261 | $16 |
| Automated urinalysis test | 20 | $45 | $2 |
2019: 14 services
| Return visit (30+ min) | 285 | $31,889 | $80 |
| Short return visit (20+ min) | 85 | $4,987 | $52 |
| Long return visit (40+ min) | 32 | $4,223 | $117 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,152 | $135 |
| Influenza vaccine split virus, preservative free | 19 | $1,023 | $54 |
| New patient visit (30+ min) | 19 | $793 | $42 |
| Administration of influenza virus vaccine | 26 | $456 | $18 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 13 | $350 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $307 | $12 |
| Injection of drug or substance under skin or into muscle | 19 | $272 | $14 |
| Detection test by immunoassay with direct visual observation for influenza virus | 14 | $243 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $243 | $16 |
| Automated urinalysis test | 44 | $112 | $2 |
| Injection, ketorolac tromethamine, per 15 mg | 11 | $10 | None |
2018: 14 services
| Return visit (30+ min) | 247 | $27,808 | $77 |
| Short return visit (20+ min) | 75 | $4,543 | $50 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $3,730 | $133 |
| Long return visit (40+ min) | 19 | $2,666 | $121 |
| New patient visit (45+ min) | 17 | $1,532 | $90 |
| Influenza vaccine split virus, preservative free | 21 | $1,118 | $51 |
| New patient visit (30+ min) | 14 | $734 | $52 |
| Administration of influenza virus vaccine | 31 | $693 | $22 |
| Injection of drug or substance under skin or into muscle | 20 | $348 | $17 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $334 | $12 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 18 | $329 | $16 |
| Administration of pneumococcal vaccine | 14 | $303 | $22 |
| Automated urinalysis test | 31 | $84 | $3 |
| Injection, ketorolac tromethamine, per 15 mg | 12 | $18 | None |
2017: 11 services
| Return visit (30+ min) | 222 | $24,820 | $84 |
| Short return visit (20+ min) | 134 | $8,953 | $56 |
| New patient visit (45+ min) | 26 | $2,925 | $113 |
| Long return visit (40+ min) | 17 | $2,456 | $129 |
| New patient visit (30+ min) | 23 | $1,396 | $61 |
| Influenza vaccine split virus, preservative free | 24 | $1,147 | $48 |
| Administration of influenza virus vaccine | 24 | $648 | $27 |
| Injection of drug or substance under skin or into muscle | 17 | $389 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 20 | $291 | $13 |
| Urinalysis, manual test | 21 | $75 | $3 |
| Automated urinalysis test | 15 | $51 | $3 |
2016: 10 services
| Return visit (30+ min) | 163 | $16,493 | $78 |
| Short return visit (20+ min) | 112 | $6,893 | $51 |
| Pneumococcal vaccine, 13-valent | 11 | $1,929 | $175 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,461 | $133 |
| Administration of influenza virus vaccine | 21 | $635 | $30 |
| Influenza vaccine split virus, preservative free | 16 | $626 | $39 |
| Injection of drug or substance under skin or into muscle | 13 | $405 | $18 |
| Administration of pneumococcal vaccine | 14 | $398 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $255 | $13 |
| Automated urinalysis test | 33 | $102 | $3 |
2015: 4 services
| Return visit (30+ min) | 42 | $4,003 | $89 |
| Short return visit (20+ min) | 41 | $2,530 | $60 |
| Influenza vaccine split virus, preservative free | 12 | $427 | $36 |
| Administration of influenza virus vaccine | 12 | $319 | $27 |
Medicaid work
$30,268 in 2024
Medicaid paid $30,268 for 179 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 162 | $28,857 |
| Global fee urgent care centers | 17 | $1,411 |
| 2024 | 179 | 2 | 27 | $30,268 |
| 2023 | 314 | 2 | 36 | $46,771 |
| 2022 | 607 | 2 | 41 | $32,644 |
| 2021 | 379 | 2 | 39 | $12,729 |
| 2020 | 271 | 1 | 28 | $4,148 |
| 2019 | 247 | 3 | 25 | $5,089 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 207 | $39,097 |
| Global fee urgent care centers | 107 | $7,674 |
2022
| Global fee urgent care centers | 225 | $16,399 |
| Return visit (30+ min) | 382 | $16,245 |
2021
| Return visit (30+ min) | 307 | $7,404 |
| Global fee urgent care centers | 72 | $5,325 |
2020
| Return visit (30+ min) | 271 | $4,148 |
2019
| Global fee urgent care centers | 39 | $2,925 |
| Return visit (30+ min) | 163 | $1,724 |
| Short return visit (20+ min) | 45 | $440 |
Drugs they prescribed that Part D paid
$7,731
Pharmacies billed $7,731 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
430 generic and fewer than 11 brand-name prescriptions · $7,731 in drug cost · 202 antibiotic prescriptions to 186 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 27 | $559 | $21 |
| Cephalexin | 69 | $335 | $5 |
| Amoxicillin-Clavulanate Potass | 41 | $312 | $8 |
| Fluticasone Propionate | 12 | $255 | $21 |
| Mupirocin | 23 | $174 | $8 |
See all 10 drugs
| Albuterol Sulfate Hfa | 27 | $559 | $21 |
| Cephalexin | 69 | $335 | $5 |
| Amoxicillin-Clavulanate Potass | 41 | $312 | $8 |
| Fluticasone Propionate | 12 | $255 | $21 |
| Mupirocin | 23 | $174 | $8 |
| Azithromycin | 53 | $154 | $3 |
| Benzonatate | 16 | $85 | $5 |
| Prednisone | 33 | $57 | $2 |
| Meloxicam | 17 | $28 | $2 |
| Paxlovid | 13 | $0 | $0 |
Year by year
| 2024 | 480 | 315 | None | None | $7,731 |
| 2023 | 734 | 377 | None | 9% | $37,656 |
| 2022 | 2,367 | 331 | 6% (140) | 12% | $232,972 |
| 2021 | 2,380 | 253 | 6% (147) | 14% | $251,829 |
| 2020 | 2,184 | 254 | 4% (87) | None | $187,734 |
| 2019 | 1,762 | 309 | 5% (89) | 18% | $160,129 |
| 2018 | 1,417 | 248 | 6% (89) | 15% | $110,583 |
| 2017 | 940 | 206 | 6% (60) | 11% | $45,481 |
| 2016 | 535 | 147 | 8% (41) | None | $13,799 |
| 2015 | 334 | 102 | 7% (23) | 19% | $17,919 |
| 2014 | 245 | 71 | 11% (27) | None | $10,998 |
| 2013 | 23 | 13 | None | 0% | $294 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Eliquis | 15 | $11,788 | $786 |
| Januvia | 14 | $10,675 | $763 |
| Albuterol Sulfate Hfa | 21 | $709 | $34 |
| Cephalexin | 66 | $508 | $8 |
| Losartan | 21 | $423 | $20 |
| Atorvastatin | 21 | $335 | $16 |
| Gabapentin | 12 | $325 | $27 |
| Omeprazole | 12 | $312 | $26 |
| Amoxicillin-Clavulanate Potass | 34 | $305 | $9 |
| Doxycycline Hyclate | 19 | $291 | $15 |
| Azithromycin | 47 | $285 | $6 |
| Amlodipine Besylate | 30 | $208 | $7 |
| Paxlovid (Eua) | 18 | $189 | $11 |
| Metformin | 14 | $131 | $9 |
| Mupirocin | 12 | $122 | $10 |
| Cyclobenzaprine | 13 | $92 | $7 |
| Prednisone | 25 | $77 | $3 |
2022: 69 drugs
| Eliquis | 37 | $33,288 | $900 |
| Januvia | 15 | $19,788 | $1,319 |
| Buprenorphine-Naloxone | 134 | $18,049 | $135 |
| Buprenorphine | 37 | $15,157 | $410 |
| Belbuca | 16 | $11,888 | $743 |
| Suboxone | 17 | $9,987 | $587 |
| Zubsolv | 14 | $9,913 | $708 |
| Xarelto | 11 | $8,131 | $739 |
| Lantus Solostar | 15 | $6,515 | $434 |
| Buprenorphine | 55 | $6,497 | $118 |
| Duloxetine | 60 | $3,218 | $54 |
| Atorvastatin | 108 | $1,506 | $14 |
| Albuterol Sulfate Hfa | 35 | $1,481 | $42 |
| Gabapentin | 61 | $1,165 | $19 |
| Hydrocodone-Acetaminophen | 49 | $1,142 | $23 |
| Omeprazole | 43 | $1,019 | $24 |
| Desloratadine | 13 | $783 | $60 |
| Diclofenac | 17 | $782 | $46 |
| Rosuvastatin | 26 | $780 | $30 |
| Cyclobenzaprine | 34 | $732 | $22 |
| Pantoprazole | 30 | $723 | $24 |
| Oxycodone-Acetaminophen | 18 | $718 | $40 |
| Ventolin Hfa | 11 | $675 | $61 |
| Pregabalin | 22 | $652 | $30 |
| Levothyroxine | 25 | $599 | $24 |
| Metformin | 67 | $552 | $8 |
| Metoprolol | 28 | $509 | $18 |
| Fluticasone Propionate | 24 | $499 | $21 |
| Losartan | 41 | $485 | $12 |
| Trazodone | 29 | $468 | $16 |
| Amlodipine Besylate | 77 | $424 | $6 |
| Doxycycline Hyclate | 18 | $385 | $21 |
| Montelukast | 14 | $365 | $26 |
| Simvastatin | 33 | $351 | $11 |
| Methadone | 17 | $337 | $20 |
| Amoxicillin-Clavulanate Potass | 24 | $316 | $13 |
| Glipizide Er | 17 | $312 | $18 |
| Quetiapine | 16 | $305 | $19 |
| Hydroxyzine | 15 | $305 | $20 |
| Carvedilol | 19 | $290 | $15 |
| Paxlovid (Eua) | 29 | $278 | $10 |
| Hydralazine | 11 | $270 | $25 |
| Cephalexin | 56 | $262 | $5 |
| Tamsulosin | 24 | $259 | $11 |
| Lisinopril | 42 | $257 | $6 |
| Lorazepam | 33 | $253 | $8 |
| Potassium Chloride | 17 | $239 | $14 |
| Ondansetron Odt | 14 | $215 | $15 |
| Baclofen | 11 | $210 | $19 |
| Allopurinol | 16 | $196 | $12 |
| Famotidine | 13 | $185 | $14 |
| Hydrochlorothiazide | 28 | $183 | $7 |
| Clopidogrel | 12 | $175 | $15 |
| Azithromycin | 25 | $173 | $7 |
| Atenolol | 19 | $165 | $9 |
| Mupirocin | 16 | $161 | $10 |
| Furosemide | 14 | $149 | $11 |
| Temazepam | 16 | $147 | $9 |
| Promethazine | 26 | $146 | $6 |
| Lovastatin | 12 | $117 | $10 |
| Sertraline | 13 | $111 | $9 |
| Prednisone | 22 | $96 | $4 |
| Metformin Hcl Er | 11 | $90 | $8 |
| Buspirone | 12 | $89 | $7 |
| Metoprolol | 13 | $85 | $7 |
| Lisinopril-Hydrochlorothiazide | 11 | $68 | $6 |
| Sulfamethoxazole-Trimethoprim | 12 | $47 | $4 |
| Ibuprofen | 11 | $46 | $4 |
| Amitriptyline | 13 | $42 | $3 |
2021: 67 drugs
| Victoza 3-Pak | 22 | $23,098 | $1,050 |
| Buprenorphine | 63 | $22,626 | $359 |
| Eliquis | 25 | $21,787 | $871 |
| Buprenorphine-Naloxone | 120 | $20,388 | $170 |
| Januvia | 11 | $17,465 | $1,588 |
| Suboxone | 28 | $14,819 | $529 |
| Zubsolv | 17 | $13,609 | $801 |
| Symbicort | 15 | $5,861 | $391 |
| Buprenorphine | 87 | $5,269 | $61 |
| Duloxetine | 76 | $2,167 | $29 |
| Albuterol Sulfate Hfa | 26 | $1,888 | $73 |
| Atorvastatin | 96 | $1,642 | $17 |
| Gabapentin | 83 | $1,527 | $18 |
| Omeprazole | 65 | $1,014 | $16 |
| Quetiapine | 23 | $947 | $41 |
| Methylphenidate La | 11 | $826 | $75 |
| Diclofenac | 19 | $803 | $42 |
| Oxycodone-Acetaminophen | 25 | $794 | $32 |
| Hydrocodone-Acetaminophen | 35 | $789 | $23 |
| Montelukast | 11 | $674 | $61 |
| Levothyroxine | 30 | $607 | $20 |
| Amlodipine Besylate | 83 | $518 | $6 |
| Metformin | 61 | $512 | $8 |
| Metoprolol | 30 | $503 | $17 |
| Pantoprazole | 23 | $449 | $20 |
| Allopurinol | 24 | $444 | $18 |
| Trazodone | 31 | $443 | $14 |
| Cyclobenzaprine | 32 | $396 | $12 |
| Eszopiclone | 11 | $358 | $33 |
| Losartan | 26 | $356 | $14 |
| Bupropion Hcl Sr | 17 | $351 | $21 |
| Glipizide Er | 20 | $338 | $17 |
| Pregabalin | 13 | $335 | $26 |
| Simvastatin | 26 | $313 | $12 |
| Potassium Chloride | 19 | $284 | $15 |
| Fluticasone Propionate | 17 | $284 | $17 |
| Mirtazapine | 12 | $268 | $22 |
| Lisinopril | 44 | $261 | $6 |
| Sucralfate | 14 | $253 | $18 |
| Escitalopram | 12 | $239 | $20 |
| Doxycycline Hyclate | 18 | $229 | $13 |
| Furosemide | 19 | $216 | $11 |
| Hydralazine | 12 | $214 | $18 |
| Temazepam | 20 | $199 | $10 |
| Buspirone | 18 | $195 | $11 |
| Lorazepam | 21 | $194 | $9 |
| Glimepiride | 29 | $184 | $6 |
| Benazepril | 11 | $172 | $16 |
| Famotidine | 15 | $166 | $11 |
| Metoprolol | 25 | $163 | $7 |
| Promethazine | 24 | $160 | $7 |
| Lovastatin | 17 | $145 | $9 |
| Cephalexin | 40 | $140 | $3 |
| Carvedilol | 20 | $139 | $7 |
| Amoxicillin-Clavulanate Potass | 20 | $135 | $7 |
| Hydrochlorothiazide | 26 | $133 | $5 |
| Lisinopril-Hydrochlorothiazide | 14 | $122 | $9 |
| Clotrimazole | 13 | $116 | $9 |
| Zolpidem | 21 | $111 | $5 |
| Mupirocin | 16 | $107 | $7 |
| Atenolol | 11 | $85 | $8 |
| Alprazolam | 11 | $81 | $7 |
| Ibuprofen | 11 | $77 | $7 |
| Triamcinolone Acetonide | 12 | $74 | $6 |
| Fluconazole | 12 | $47 | $4 |
| Prednisone | 11 | $46 | $4 |
| Amitriptyline | 11 | $42 | $4 |
2020: 59 drugs
| Buprenorphine-Naloxone | 147 | $23,630 | $161 |
| Zubsolv | 29 | $16,266 | $561 |
| Suboxone | 21 | $15,405 | $734 |
| Eliquis | 18 | $14,479 | $804 |
| Buprenorphine | 16 | $6,539 | $409 |
| Buprenorphine | 72 | $6,497 | $90 |
| Spiriva | 11 | $6,178 | $562 |
| Basaglar Kwikpen U-100 | 12 | $4,033 | $336 |
| Duloxetine | 59 | $1,573 | $27 |
| Albuterol Sulfate Hfa | 36 | $1,567 | $44 |
| Atorvastatin | 73 | $1,245 | $17 |
| Celecoxib | 13 | $1,226 | $94 |
| Omeprazole | 71 | $950 | $13 |
| Oxycodone-Acetaminophen | 23 | $869 | $38 |
| Levothyroxine | 30 | $821 | $27 |
| Amlodipine Besylate | 70 | $581 | $8 |
| Hydrocodone-Acetaminophen | 36 | $559 | $16 |
| Metformin | 51 | $544 | $11 |
| Gabapentin | 42 | $543 | $13 |
| Metoprolol | 29 | $491 | $17 |
| Fluticasone Propionate | 23 | $461 | $20 |
| Eszopiclone | 12 | $435 | $36 |
| Potassium Chloride | 23 | $416 | $18 |
| Losartan | 28 | $350 | $13 |
| Pantoprazole | 13 | $336 | $26 |
| Lisinopril | 44 | $334 | $8 |
| Diclofenac | 15 | $311 | $21 |
| Lovastatin | 20 | $310 | $15 |
| Sucralfate | 15 | $303 | $20 |
| Quetiapine | 14 | $282 | $20 |
| Trazodone | 34 | $270 | $8 |
| Alfuzosin Hcl Er | 12 | $250 | $21 |
| Escitalopram | 27 | $246 | $9 |
| Benazepril | 11 | $238 | $22 |
| Famotidine | 15 | $237 | $16 |
| Allopurinol | 18 | $232 | $13 |
| Glipizide Er | 13 | $223 | $17 |
| Doxycycline Hyclate | 13 | $216 | $17 |
| Metoprolol | 28 | $208 | $7 |
| Glimepiride | 23 | $176 | $8 |
| Simvastatin | 21 | $172 | $8 |
| Azithromycin | 28 | $171 | $6 |
| Cyclobenzaprine | 23 | $165 | $7 |
| Buspirone | 12 | $162 | $14 |
| Amoxicillin-Clavulanate Potass | 15 | $161 | $11 |
| Furosemide | 28 | $143 | $5 |
| Zolpidem | 41 | $141 | $3 |
| Hydrochlorothiazide | 26 | $140 | $5 |
| Divalproex | 13 | $125 | $10 |
| Lisinopril-Hydrochlorothiazide | 12 | $118 | $10 |
| Cephalexin | 30 | $112 | $4 |
| Lorazepam | 21 | $111 | $5 |
| Clonidine | 12 | $108 | $9 |
| Ibuprofen | 21 | $79 | $4 |
| Meloxicam | 16 | $66 | $4 |
| Mirtazapine | 11 | $62 | $6 |
| Prednisone | 12 | $47 | $4 |
| Hydrocortisone | 12 | $47 | $4 |
| Temazepam | 12 | $43 | $4 |
2019: 53 drugs
| Zubsolv | 35 | $21,780 | $622 |
| Buprenorphine-Naloxone | 126 | $20,962 | $166 |
| Januvia | 14 | $15,292 | $1,092 |
| Suboxone | 31 | $14,289 | $461 |
| Buprenorphine | 27 | $9,307 | $345 |
| Buprenorphine | 60 | $4,279 | $71 |
| Narcan | 17 | $2,187 | $129 |
| Celecoxib | 13 | $1,080 | $83 |
| Gabapentin | 40 | $868 | $22 |
| Atorvastatin | 34 | $768 | $23 |
| Duloxetine | 29 | $720 | $25 |
| Levothyroxine | 29 | $711 | $25 |
| Ventolin Hfa | 12 | $682 | $57 |
| Omeprazole | 37 | $606 | $16 |
| Hydrocodone-Acetaminophen | 28 | $534 | $19 |
| Potassium Chloride | 25 | $458 | $18 |
| Metoprolol | 14 | $435 | $31 |
| Losartan | 38 | $399 | $10 |
| Zolpidem | 23 | $384 | $17 |
| Oxycodone-Acetaminophen | 15 | $369 | $25 |
| Doxycycline Hyclate | 18 | $339 | $19 |
| Diclofenac | 16 | $304 | $19 |
| Eszopiclone | 12 | $282 | $23 |
| Amlodipine Besylate | 40 | $267 | $7 |
| Fluticasone Propionate | 21 | $266 | $13 |
| Calcitriol | 11 | $266 | $24 |
| Lovastatin | 16 | $247 | $15 |
| Metformin | 34 | $239 | $7 |
| Cephalexin | 33 | $211 | $6 |
| Azithromycin | 28 | $204 | $7 |
| Escitalopram | 30 | $191 | $6 |
| Lisinopril | 23 | $186 | $8 |
| Amoxicillin-Clavulanate Potass | 16 | $179 | $11 |
| Trazodone | 30 | $177 | $6 |
| Ondansetron Odt | 21 | $161 | $8 |
| Furosemide | 35 | $146 | $4 |
| Ranitidine | 11 | $143 | $13 |
| Simvastatin | 18 | $132 | $7 |
| Mupirocin | 12 | $113 | $9 |
| Glimepiride | 14 | $109 | $8 |
| Warfarin | 12 | $90 | $8 |
| Atenolol | 12 | $87 | $7 |
| Cyclobenzaprine | 16 | $87 | $5 |
| Tramadol | 14 | $82 | $6 |
| Mirtazapine | 13 | $76 | $6 |
| Amitriptyline | 13 | $69 | $5 |
| Metoprolol | 16 | $62 | $4 |
| Hydrochlorothiazide | 18 | $62 | $3 |
| Sulfamethoxazole-Trimethoprim | 13 | $60 | $5 |
| Famotidine | 12 | $54 | $5 |
| Prednisone | 21 | $51 | $2 |
| Temazepam | 11 | $39 | $4 |
| Lorazepam | 12 | $29 | $2 |
2018: 39 drugs
| Buprenorphine-Naloxone | 85 | $16,625 | $196 |
| Suboxone | 24 | $12,632 | $526 |
| Zubsolv | 22 | $12,411 | $564 |
| Buprenorphine | 19 | $7,362 | $387 |
| Levemir Flextouch | 11 | $5,502 | $500 |
| Buprenorphine | 59 | $3,501 | $59 |
| Ventolin Hfa | 18 | $993 | $55 |
| Gabapentin | 31 | $831 | $27 |
| Proair Hfa | 13 | $822 | $63 |
| Duloxetine | 19 | $670 | $35 |
| Atorvastatin | 33 | $573 | $17 |
| Hydrocodone-Acetaminophen | 40 | $552 | $14 |
| Levothyroxine | 18 | $424 | $24 |
| Diclofenac | 13 | $335 | $26 |
| Amlodipine Besylate | 25 | $302 | $12 |
| Lisinopril | 32 | $299 | $9 |
| Omeprazole | 37 | $299 | $8 |
| Metformin | 27 | $299 | $11 |
| Simvastatin | 24 | $248 | $10 |
| Azithromycin | 37 | $230 | $6 |
| Allopurinol | 12 | $206 | $17 |
| Potassium Chloride | 18 | $193 | $11 |
| Cephalexin | 28 | $181 | $6 |
| Amitriptyline | 18 | $166 | $9 |
| Losartan | 23 | $155 | $7 |
| Bisoprolol | 11 | $153 | $14 |
| Atenolol | 17 | $150 | $9 |
| Mirtazapine | 13 | $135 | $10 |
| Warfarin | 12 | $127 | $11 |
| Escitalopram | 19 | $108 | $6 |
| Furosemide | 23 | $106 | $5 |
| Alendronate | 11 | $103 | $9 |
| Trazodone | 17 | $90 | $5 |
| Mupirocin | 11 | $90 | $8 |
| Metoprolol | 23 | $61 | $3 |
| Hydrochlorothiazide | 18 | $45 | $3 |
| Lorazepam | 15 | $44 | $3 |
| Tramadol | 15 | $43 | $3 |
| Prednisone | 14 | $30 | $2 |
2017: 30 drugs
| Suboxone | 12 | $5,950 | $496 |
| Buprenorphine-Naloxone | 19 | $5,433 | $286 |
| Buprenorphine | 27 | $1,205 | $45 |
| Hydrocodone-Acetaminophen | 36 | $580 | $16 |
| Atorvastatin | 22 | $507 | $23 |
| Metformin | 22 | $313 | $14 |
| Levothyroxine | 11 | $299 | $27 |
| Diclofenac | 17 | $273 | $16 |
| Omeprazole | 29 | $251 | $9 |
| Lovastatin | 13 | $246 | $19 |
| Azithromycin | 33 | $228 | $7 |
| Lisinopril | 24 | $213 | $9 |
| Bisoprolol | 11 | $178 | $16 |
| Losartan | 20 | $167 | $8 |
| Amoxicillin-Clavulanate Potass | 12 | $154 | $13 |
| Citalopram Hbr | 21 | $137 | $7 |
| Sucralfate | 11 | $122 | $11 |
| Cephalexin | 26 | $115 | $4 |
| Simvastatin | 22 | $99 | $4 |
| Mupirocin | 12 | $97 | $8 |
| Pioglitazone | 11 | $81 | $7 |
| Mirtazapine | 11 | $65 | $6 |
| Lorazepam | 13 | $56 | $4 |
| Zolpidem | 11 | $55 | $5 |
| Amoxicillin | 12 | $52 | $4 |
| Tramadol | 18 | $51 | $3 |
| Amlodipine Besylate | 12 | $47 | $4 |
| Metoprolol | 15 | $43 | $3 |
| Hydrochlorothiazide | 15 | $39 | $3 |
| Furosemide | 15 | $38 | $3 |
2016: 15 drugs
| Hydrocodone-Acetaminophen | 19 | $346 | $18 |
| Lovastatin | 19 | $323 | $17 |
| Nitrofurantoin Mono-Macro | 16 | $258 | $16 |
| Gabapentin | 22 | $222 | $10 |
| Metformin | 19 | $220 | $12 |
| Ondansetron Odt | 13 | $172 | $13 |
| Cephalexin | 17 | $106 | $6 |
| Azithromycin | 19 | $100 | $5 |
| Losartan | 11 | $93 | $8 |
| Lorazepam | 16 | $87 | $5 |
| Omeprazole | 18 | $72 | $4 |
| Hydrochlorothiazide | 17 | $63 | $4 |
| Simvastatin | 12 | $63 | $5 |
| Donepezil | 11 | $49 | $4 |
| Citalopram Hbr | 17 | $38 | $2 |
2015: 8 drugs
| Hydrocodone-Acetaminophen | 11 | $363 | $33 |
| Citalopram Hbr | 13 | $162 | $12 |
| Donepezil | 12 | $104 | $9 |
| Azithromycin | 14 | $89 | $6 |
| Cephalexin | 12 | $87 | $7 |
| Hydrochlorothiazide | 11 | $79 | $7 |
| Omeprazole | 13 | $71 | $5 |
| Furosemide | 12 | $56 | $5 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 22 | $446 | $20 |
| Gabapentin | 14 | $127 | $9 |
Professional record
- NPI
- 1720345895
- Licence
- CA A126918California A126918: Current · expires 2027-03-31
- Trained
- University of Michigan Medical School, 2012
- Group
- Sutter Valley Medical Foundation · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 10470 Old Placerville Rd, Suite 10, Sacramento, CA, 95827
- NPI first listed
- 2012-04-13
- NPI last updated
- 2015-07-07
This is when the NPI record was last certified, not a medical board exam.